The Enterprise Value as of December 2025 (TTM) for Viking Therapeutics, Inc. (0VQA.L) is 4.09B

According to Viking Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 4.09B. This represents a change of 26.61% compared to the average of 3.23B of the last 4 quarters.

Viking Therapeutics, Inc. (0VQA.L) Historical Enterprise Value (quarterly & annually)

How has 0VQA.L Enterprise Value performed in the past?

The mean historical Enterprise Value of Viking Therapeutics, Inc. over the last ten years is 858.72M. The current 4.09B Enterprise Value has changed 47.51% with respect to the historical average. Over the past ten years (40 quarters), 0VQA.L's Enterprise Value was at its highest in in the March 2024 quarter at 8.03B. The Enterprise Value was at its lowest in in the March 2016 quarter at 11.98M.

Viking Therapeutics, Inc. (0VQA.L) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Viking Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Viking Therapeutics, Inc. (0VQA.L) Average Enterprise Value

How has 0VQA.L Enterprise Value performed in the past?

The current Enterprise Value of Viking Therapeutics, Inc. (0VQA.L) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Viking Therapeutics, Inc. (0VQA.L) Enterprise Value vs. Peers

How is 0VQA.L’s Enterprise Value compared to its peers?

Viking Therapeutics, Inc.’s Enterprise Value is less than TG Therapeutics, Inc. (5.10B), greater than Supernus Pharmaceuticals, Inc. (-117308365171.00), greater than Perrigo Company plc (1.41B), greater than Amicus Therapeutics, Inc. (3.51B), less than Axsome Therapeutics, Inc. (7.36B), greater than Agios Pharmaceuticals, Inc. (1.54B), greater than Sarepta Therapeutics, Inc. (2.75B), less than Arrowhead Pharmaceuticals, Inc. (10.27B), greater than uniQure N.V. (525.12M), greater than Nektar Therapeutics (1.16B),

Build a custom stock screener for Viking Therapeutics, Inc. (0VQA.L) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Viking Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Viking Therapeutics, Inc. (0VQA.L) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Viking Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.